April 12, 2018 / 12:03 PM / 7 months ago

BRIEF-Pfizer Doses First Patient Using Investigational Mini Dystrophin Gene Therapy For The Treatment Of Duchenne Muscular Dystrophy

April 12 (Reuters) - Pfizer Inc:

* PFIZER DOSES FIRST PATIENT USING INVESTIGATIONAL MINI-DYSTROPHIN GENE THERAPY FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

* EARLY DATA FROM MINI-DYSTROPHIN GENE THERAPY STUDY TRIAL ARE EXPECTED IN FIRST HALF OF 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below